​

Jazz Pharmaceuticals Ownership | Who Owns Jazz Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Jazz Pharmaceuticals Ownership Summary

Jazz Pharmaceuticals is owned by 100.88% institutional investors, 3.12% insiders. Vanguard group is the largest institutional shareholder, holding 9.83% of JAZZ shares. Pacer US Cash Cows 100 ETF is the top mutual fund, with 3.55% of its assets in Jazz Pharmaceuticals shares.

JAZZ Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockJazz Pharmaceuticals100.88%3.12%-3.99%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%
IdeaCannabis Stocks List18.72%11.24%70.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group6.04M9.83%$743.36M
Blackrock6.15M9.83%$655.94M
Blackrock funding, inc. /de5.80M9.48%$615.47M
Lsv asset management2.55M4.17%$271.00M
Capital world investors2.54M4.16%$270.02M
Pacer advisors2.21M3.61%$272.71M
Dimensional fund advisors lp2.04M3.31%$250.62M
State street2.02M3.23%$215.31M
Ameriprise financial1.83M2.98%$225.08M
Ecor1 capital1.71M2.78%$210.15M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management164.82K9.26%$17.49M
Saturn v capital management206.95K8.90%$21.96M
Estuary capital management lp232.52K8.37%$28.63M
Ecor1 capital1.71M7.95%$210.15M
Vestal point capital, lp1.20M6.70%$127.34M
Polaris capital management1.09M6.45%$133.72M
Superstring capital management lp44.11K5.54%$4.68M
Logos global management lp450.00K5.28%$47.75M
Sofinnova investments694.10K4.50%$73.66M
Acuta capital partners26.28K3.89%$2.79M

Top Buyers

HolderShares% AssetsChange
Vestal point capital, lp1.20M6.70%1.20M
Capital world investors2.54M0.04%616.73K
Logos global management lp450.00K5.28%450.00K
Dimensional fund advisors lp2.04M0.06%320.72K
Ameriprise financial1.83M0.06%315.61K

Top Sellers

HolderShares% AssetsChange
Baupost group llc/ma---1.27M
Camber capital management lp---1.15M
Blackrock6.15M0.01%-924.16K
Rubric capital management lp---616.62K
Darwin global management---484.51K

New Positions

HolderShares% AssetsChangeValue
Saturn v capital management206.95K8.90%206.95K$21.96M
Centre asset management75.80K2.14%75.80K$9.34M
O'shaughnessy asset management44.82K0.05%44.82K$5.52M
Superstring capital management lp44.11K5.54%44.11K$4.68M
Ikarian capital40.00K0.82%40.00K$4.24M

Sold Out

HolderChange
Harbor investment advisory-1.00
Psi advisors-1.00
Center for financial planning-1.00
Hexagon capital partners-2.00
Financial gravity asset management-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025498-10.75%61,731,8556.44%1001.12%243-23.10%17512.18%
Mar 31, 20255528.02%58,706,955-0.60%961.04%31219.54%155-7.74%
Dec 31, 2024468-2.50%56,158,556-2.64%911.04%238-155-1.27%
Sep 30, 20244732.83%57,472,0080.00%931.12%2357.31%155-6.06%
Jun 30, 2024456-6.37%57,467,965-0.65%911.10%218-6.84%1620.62%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Pacer US Cash Cows 100 ETF2.16M3.55%3.19K
iShares Core S&P Mid-Cap ETF2.01M3.31%-3.63K
American Funds Fundamental Invs A2.00M3.31%105.19K
Capital Group Fundamental Invtrs Comp2.00M3.31%105.19K
Vanguard Total Stock Mkt Idx Inv1.85M3.04%-45.46K
Vanguard US Total Market Shares ETF1.84M3.03%-44.10K
Vanguard Small Cap Index1.42M2.35%-8.43K
FullerThaler Behavioral Small-Cap Equity1.27M2.09%369.80K
FullerThaler Behavioral Sm-Cp Eq R61.27M2.06%369.80K
JPMorgan Mid Cap Value L918.70K1.52%5.40K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 02, 2025COZADD BRUCE C-Sell$381.69K
Sep 02, 2025COZADD BRUCE C-Sell$390.00K
Aug 01, 2025COZADD BRUCE C Chairman & CEOSell$113.21K
Jul 01, 2025COZADD BRUCE C Chairman & CEOSell$52.63K
Jul 01, 2025COZADD BRUCE C Chairman & CEOSell$55.00K

Insider Transactions Trends

DateBuySell
2025 Q3-5
2025 Q245
2025 Q1-10
2024 Q4-4
2024 Q3-1

JAZZ Ownership FAQ

Who Owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals shareholders are primarily institutional investors at 100.88%, followed by 3.12% insiders and -4.00% retail investors. The average institutional ownership in Jazz Pharmaceuticals's industry, Biotech Stocks , is 306.59%, which Jazz Pharmaceuticals falls below.

Who owns the most shares of Jazz Pharmaceuticals?

Jazz Pharmaceuticals’s largest shareholders are Vanguard group (6.04M shares, 9.83%), Blackrock (6.15M shares, 9.83%), and Blackrock funding, inc. /de (5.8M shares, 9.48%). Together, they hold 29.13% of Jazz Pharmaceuticals’s total shares outstanding.

Does Blackrock own Jazz Pharmaceuticals?

Yes, BlackRock owns 9.83% of Jazz Pharmaceuticals, totaling 6.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 655.94M$. In the last quarter, BlackRock decreased its holdings by -924K shares, a -13.07% change.

Who is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 9.26% of its assets in 164.82K Jazz Pharmaceuticals shares, valued at 17.49M$.

Who is the top mutual fund holder of Jazz Pharmaceuticals shares?

Pacer US Cash Cows 100 ETF is the top mutual fund holder of Jazz Pharmaceuticals shares, with 3.55% of its total shares outstanding invested in 2.16M Jazz Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools